ClinicalTrials.gov
public full text
Public Domain
Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Daylight-PDT With MAL for AK and Photodamaged Skin#1044466
- Transcutaneous Electrical Acupoint Stimulation at Jing-Well Points for Disorders of Consciousness#1007674
- Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis#1137892
- Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis Patients#1138154
- Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma.#444888
Record · ID 253008
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive